Analystreport

Biohaven Pharmaceutical Holding Co Ltd (NYSE: BHVN) had its "outperform" rating re-affirmed by analysts at Leerink Swann. They now have a $64.00 price target on the stock, up previously f...

Biohaven Pharmaceutical Holding Company Ltd. Common Shares  (BHVN) 
Last biohaven pharmaceutical holding company ltd. common shares earnings: 2/25 04:45 pm Check Earnings Report
US:NYSE Investor Relations: investors.biohavenpharma.com